Search results
Results from the WOW.Com Content Network
PDL BioPharma (known as Protein Design Labs prior to 2006) is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company.
PDL BioPharma (PDLI) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. PDL BioPharma (PDLI) is an inspired choice for value ...
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks ...
Shares of PDL BioPharma (NAS: PDLI) recently hit a new 52-week high. The stock has soared 55% so far this year. Will PDL continue to fly high, or is a crash possibly in the wings? Let's take a look.
For premium support please call: 800-290-4726 more ways to reach us
PDL Biopharma (NAS: PDLI) is trading near a 52-week high, and its share price has appreciated more than 30% year to date. This company's revenue comes from licensing its valuable intellectual ...
PDLI earnings call for the period ending March 31, 2019.
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, antibody humanization patent manager PDL BioPharma (NAS: PDLI ...